Close Menu

NEW YORK (GenomeWeb) – Novacyt said today that it has completed a €3 million ($3.3 million) private financing.

The clinical diagnostics firm will use net proceeds from the fundraising to invest in a new manufacturing facility in Camberley, UK, to accommodate increased manufacturing of Lab21 clinical laboratory products and the NOVAprep liquid-based cytology platform for cervical cancer screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.